THE EFFECT OF 1-ALPHA-HYDROXYVITAMIN-D3 ON CELL-MEDIATED-IMMUNITY IN HEMODIALYZED PATIENTS

被引:46
作者
TABATA, T
SUZUKI, R
KIKUNAMI, K
MATSUSHITA, Y
INOUE, T
INOUE, T
OKAMOTO, T
MIKI, T
NISHIZAWA, Y
MORII, H
机构
[1] ASHIHARA HOSP, NANIWA KU, OSAKA, JAPAN
[2] OSAKA CITY UNIV, SCH MED, DEPT INTERNAL MED 2, ABENO KU, OSAKA 545, JAPAN
关键词
D O I
10.1210/jcem-63-5-1218
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1218 / 1221
页数:4
相关论文
共 24 条
[1]   DIFFERENTIATION OF MOUSE MYELOID-LEUKEMIA CELLS INDUCED BY 1-ALPHA,25-DIHYDROXYVITAMIN-D3 [J].
ABE, E ;
MIYAURA, C ;
SAKAGAMI, H ;
TAKEDA, M ;
KONNO, K ;
YAMAZAKI, T ;
YOSHIKI, S ;
SUDA, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (08) :4990-4994
[2]   1-ALPHA,25-DIHYDROXYVITAMIN-D3 INDUCES MATURATION OF THE HUMAN MONOCYTE CELL-LINE U937, AND, IN ASSOCIATION WITH A FACTOR FROM HUMAN LYMPHOCYTES-T, AUGMENTS PRODUCTION OF THE MONOKINE, MONONUCLEAR CELL FACTOR [J].
AMENTO, EP ;
BHALLA, AK ;
KURNICK, JT ;
KRADIN, RL ;
CLEMENS, TL ;
HOLICK, SA ;
HOLICK, MF ;
KRANE, SM .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 73 (03) :731-739
[3]   SPECIFIC HIGH-AFFINITY RECEPTORS FOR 1,25-DIHYDROXYVITAMIN-D3 IN HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS - PRESENCE IN MONOCYTES AND INDUCTION IN LYMPHOCYTES-T FOLLOWING ACTIVATION [J].
BHALLA, AK ;
AMENTO, EP ;
CLEMENS, TL ;
HOLICK, MF ;
KRANE, SM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (06) :1308-1310
[4]  
BHALLA AK, 1984, J IMMUNOL, V133, P1748
[5]   DETERMINATION OF B LYMPHOCYTE POPULATION USING ANTIBODY-COATED POLYACRYLAMIDE BEADS [J].
CHAO, W ;
YOKOYAMA, MM .
CLINICA CHIMICA ACTA, 1977, 78 (01) :79-84
[6]  
CHRISTIANSEN C, 1981, CLIN NEPHROL, V15, P18
[7]   IMMUNODEFICIENCY IN CHRONIC UREMIA - PRELIMINARY EVIDENCE FOR THYMOSIN DEFICIENCY [J].
HARRIS, J ;
SENGAR, D ;
RASHID, A ;
HYSLOP, D ;
GREEN, L ;
GOLDSTEIN, AL .
TRANSPLANTATION, 1975, 20 (02) :176-178
[8]  
HARWICK HJ, 1978, NEPHRON, V23, P293
[9]   SERUM CONCENTRATIONS OF METABOLITES OF VITAMIN-D IN PATIENTS WITH CHRONIC-RENAL-FAILURE (CRF) - CONSEQUENCES FOR THE TREATMENT WITH 1-ALPHA-HYDROXY-DERIVATIVES [J].
JUTTMANN, JR ;
BUURMAN, CJ ;
DEKAM, E ;
VISSER, TJ ;
BIRKENHAGER, JC .
CLINICAL ENDOCRINOLOGY, 1981, 14 (03) :225-236
[10]  
KAUFFMAN CA, 1975, CLIN EXP IMMUNOL, V22, P54